Bexorg, Inc.

Bexorg, Inc. company information, Employees & Contact Information

Explore related pages

Related company profiles:

Bexorg is a privately held techbio company with the first-ever full tech stack platform to support CNS drug discovery and development in the human brain in a way that has not been possible before.  Our proprietary whole-brain perfusion technology can be used to study brain connectivity, circuit function, and disease processes, with the aim to identify novel targets, biomarkers, and effectiveness of therapeutics for neurological disorders before going into the clinic. Our proprietary BrainEx platform generates high-fidelity human brain molecular datasets that drive our XO Digital application, a machine learning and AI-centered engine for drug discovery and development. In collaboration with the NIH, Bexorg’s founders have been at the forefront of bioethics in post-mortem human brain scientific research, and we have an independent board comprised of bioethics leaders to ensure our operations maintain the highest standards. Bexorg is strategically partnering with leading neuroscience companies to integrate its platform into CNS clinical development programs, as well as advancing in-house neurodegeneration assets.

Company Details

Employees
27
Founded
-
Address
-, New Haven,ct 06519,united States
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
New Haven, CT
Looking for a particular Bexorg, Inc. employee's phone or email?

Bexorg, Inc. Questions

News

Bexorg Raises $42.5M to Transform CNS Drug Development with World’s First Integrated AI and Whole-Human Brain Platform - Yahoo Finance

Bexorg Raises $42.5M to Transform CNS Drug Development with World’s First Integrated AI and Whole-Human Brain Platform Yahoo Finance

Neuroscience start-up Bexorg nets $42.5 million - Chemical & Engineering News

Neuroscience start-up Bexorg nets $42.5 million Chemical & Engineering News

Bexorg wins $23M to end CNS drug trial failures using AI — and human brains - FirstWord Pharma

Bexorg wins $23M to end CNS drug trial failures using AI — and human brains FirstWord Pharma

New Haven startup Bexorg uses donated brains to reshape drug discovery - Hartford Business Journal

New Haven startup Bexorg uses donated brains to reshape drug discovery Hartford Business Journal

Bexorg Raises $42.5 Million Led by Engine Ventures to Advance AI and Whole-Human Brain Platform for CNS Drug Discovery - citybiz

Bexorg Raises $42.5 Million Led by Engine Ventures to Advance AI and Whole-Human Brain Platform for CNS Drug Discovery citybiz

Yale spinout raises $23M to test drugs on ‘rebooted’ human brains from organ donors - Endpoints News

Yale spinout raises $23M to test drugs on ‘rebooted’ human brains from organ donors Endpoints News

Connecticut Innovations' AI/Q Fund Invests in Two Frontier AI Opportunities: Yuma Asset Management and Bexorg - PR Newswire

Connecticut Innovations' AI/Q Fund Invests in Two Frontier AI Opportunities: Yuma Asset Management and Bexorg PR Newswire

Transforming CNS drug discovery using ‘reactivated’ human brains - Longevity.Technology

Transforming CNS drug discovery using ‘reactivated’ human brains Longevity.Technology

Bexorg Announces Research Collaboration with Biohaven Leveraging Its Novel AI-Driven Whole-Brain Discovery Platform to Enhance CNS Drug Development - Yahoo Finance

Bexorg Announces Research Collaboration with Biohaven Leveraging Its Novel AI-Driven Whole-Brain Discovery Platform to Enhance CNS Drug Development Yahoo Finance

Biohaven (BHVN) Teams Up with Bexorg for CNS Disorder Research C - GuruFocus

Biohaven (BHVN) Teams Up with Bexorg for CNS Disorder Research C GuruFocus

Exclusive: Rebooting dead human brains, a biotech startup seeks to reinvent early drug testing work - Endpoints News

Exclusive: Rebooting dead human brains, a biotech startup seeks to reinvent early drug testing work Endpoints News

New Haven-based bioscience firms Bexorg, Biohaven agree to collaborate - Hartford Business Journal

New Haven-based bioscience firms Bexorg, Biohaven agree to collaborate Hartford Business Journal

Biohaven Ltd. (BHVN) Collaborates with Bexorg, Inc to Target Central Nervous System Disorders - Yahoo Finance

Biohaven Ltd. (BHVN) Collaborates with Bexorg, Inc to Target Central Nervous System Disorders Yahoo Finance

Eight years ago, this crypto billionaire went all in on Ethereum. Why has he become fascinated with longevity science? - Bitget

Eight years ago, this crypto billionaire went all in on Ethereum. Why has he become fascinated with longevity science? Bitget

Biohaven, Bexorg Partner to Accelerate CNS Drug Discovery Using Novel Whole-Brain Platform - Yahoo Finance

Biohaven, Bexorg Partner to Accelerate CNS Drug Discovery Using Novel Whole-Brain Platform Yahoo Finance

New Haven brain research biotech startup raises $23 million - Hartford Business Journal

New Haven brain research biotech startup raises $23 million Hartford Business Journal

CT innovations invests in AI ventures in Stamford, New Haven - Hartford Business Journal

CT innovations invests in AI ventures in Stamford, New Haven Hartford Business Journal

How a Winning Bet on Crypto Could Transform Brain and Longevity Science - Bloomberg.com

How a Winning Bet on Crypto Could Transform Brain and Longevity Science Bloomberg.com

age1 Closes $35 Million To Invest In Longevity Biotech Companies - Pulse 2.0

age1 Closes $35 Million To Invest In Longevity Biotech Companies Pulse 2.0

What is the way forward for longevity? - Longevity.Technology

What is the way forward for longevity? Longevity.Technology

Top Bexorg, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant